SEC Form 4 · accession 0001209191-15-072623
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Lo
Officer — VP Commercial Operations
Period of report
Sep 29, 2015
Accepted (ET)
Sep 30, 2015 · 7:25 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Sep 29, 2015 | M | 108,333 | $2.70 | A | 108,333 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock optionF3,F2 | $2.70 | Sep 29, 2015 | M | 108,333 | D | — | Oct 10, 2022 | Common stock | 108,333 | 33,333 | D |
Explanation of responses
- F1Exercise and hold.
- F2Fully exerciseable.
- F358,334 shares were cancelled upon termination of employment.